Prognostic significance of atrial functional mitral regurgitation in patients with HFpEF and end-stage renal disease - Takeaways - MDSpire

Prognostic significance of atrial functional mitral regurgitation in patients with HFpEF and end-stage renal disease

  • By

  • Yuanyuan Wang

  • Bingya Lv

  • Yangyang Chen

  • Zhe Wang

  • Botao Hu

  • Yu Xiao

  • Haodong Du

  • Xiaoyi Zhang

  • Shuai Shao

  • Ya Suo

  • Qiankun Bao

  • May 15, 2026

  • 0 min

Share

  • 1

    Atrial functional mitral regurgitation (AFMR) significantly increases all-cause mortality in patients with heart failure with preserved ejection fraction (HFpEF) and end-stage renal disease (ESRD).

  • 2

    Multivariate analysis identified AFMR as an independent predictor of all-cause mortality, with even mild AFMR associated with elevated risk.

  • 3

    Moderate to severe AFMR correlates with a higher incidence of cardiac function decline compared to both non-AFMR and mild AFMR cohorts.

  • 4

    Plasma atrial natriuretic peptide (ANP) concentrations are significantly higher in AFMR patients and may serve as a potential biomarker for identifying AFMR.

  • 5

    The study underscores the need for prompt recognition and treatment of AFMR in patients with HFpEF and ESRD undergoing hemodialysis.

Original Source(s)

Related Content